[Magdalen] Medical update.

[Brian Reid]

That's great.
Besides your improved health, part of what's great about it is that the 
use of Colchicine to treat foot wounds is thousands of years old.

However, what is not great about old drugs is that unethical companies 
get control of the legal rights and then jack up the price. Everyone has 
heard of Martin Shkreli and his antics with Daraprim at Turing 
Pharmaceuticals. Far fewer people know that in 2009 Albert Roberts of 
URL Pharma acquired the US rights to Colchicine and then raised the 
price per tablet from $0.09 to $4.85 and sued to remove other versions 
from the market. He was not greedy enough to have his antics reported as 
national news. But Shkreli probably learned how to do this trick by 
watching Roberts.

This nasty trick only works when the drug is ancient and effective. 
Effective is good.